Advancing Therapeutics, Improving Lives
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead’s portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver disease, haematology/oncology, inflammatory and respiratory diseases, invasive fungal disease, and cardiovascular conditions.
Strength Through Partnership
Collaborations of all kinds – with partners in science, academia, business and local communities – are central to our work. Partnerships enhance our ability to develop innovative medicines and deliver them to people as efficiently as possible.
Growing Worldwide Reach
Gilead was founded in 1987 in Foster City, California. Since then we have grown to become one of the world’s largest biopharmaceutical companies with over 9,000 employees across six continents.